Ohio State University Medical Center
Older AML patients show promising response in drug study
Published in Hospital Business Week, December 28th, 2008
Preliminary findings of the phase II study suggest that older, previously untreated AML patients can achieve complete remission at a higher than expected rate when treated with the drug decitabine using a novel dosing schedule.
"This study could provide a new treatment paradigm for elderly patients with AML," says co-author Dr. John Byrd, associate director of translational...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
More Articles from Hospital Business Week
- Adam Kluger Public Relations, Inc.
Adam Kluger Public Relations AKPR Hired by Acclaimed Journalist Rivka Tadjer, Author of New Comedic Thriller, Two Weeks Under; Debut Novel About a Two-Week 'Vanity Coma Diet' SEMICOLONSIG - Adverse Drug Reactions
New Keppra XR(TM) Data Highlight Its Role for Patients with Partial-Onset Seizures - Adverse Drug Reactions
Quantros and ISMP Announce Collaboration Agreement to Further Medication Safety - Agency for Healthcare Research & Quality
Study Finds Doctors' Use of E-Prescribing Systems Linked to Formulary Data Can Boost Drug Cost Savings - Alzheimer Disease
Neuronetrix Announces Preliminary Alzheimer's Study Results at the Society for Neuroscience Conference - American Lung Association
American Lung Association Announces Support of Pickens Plan - More from this issue of Hospital Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
